Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients

• Status: Unknown status
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a pilot study that investigate efficacy and safety of Sipjeondaebo-tang on fatigue of patients with breast carcinoma receiving chemotherapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kyunghee University Medical Center
• Collaborator: Catholic Kwandong University
• Treatments: Juzentaihoto

Criteria

Inclusion Criteria:

• men and women aged over 18 years

• patients who have histologically or cytologically confirmed breast tumor

• patients who applicable AC(doxorubicin + cyclophosphamide)

• ECOG score 0 to 2

Exclusion Criteria:

• patient impossible to orally intake

• patient with dementia, delirium and depression

• patient suffering from diseases like chronic hepatitis B, C or hepatocirrhosis

• severe liver disability (3-fold the normal high range value for ALT, AST)

• patient who has diabetes not controlled by diet, hypertension, hyperthyroidism,

• severe systemic disease

• use of other investigational products within the past 30 days

• hypersensitivity to investigational product

• others who are judged not to be appropriate to study